Hal Barron (GSK via YouTube)

GSK de­clares a big win with pos­i­tive topline re­sults for its adult RSV vac­cine. But the ju­ry's still out on bot­tom line ef­fi­ca­cy

Em­ma Walm­s­ley’s bet on mak­ing GSK a pure play Big Phar­ma in­no­va­tor just cleared a ma­jor mile­stone. But the GSK team is not home free …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.